Use of statins and risk of fractures

JAMA

Volumn 285, Issue 14, 2001, Pages 1850-1855

  Van Staa, Tjeerd Pieter ^a,b,c   Wegman, Sebastiaan ^a   De Vries, Frank ^a   Leufkens, Bert ^a   Cooper, Cyrus ^c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ANTILIPEMIC AGENT; ATORVASTATIN; CERIVASTATIN; CORTICOSTEROID; FLUINDOSTATIN; HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PRAVASTATIN; SIMVASTATIN; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MECHANISM; FEMALE; FRACTURE; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT;

EID: 0035843639     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.14.1850     Document Type: Article

References (27)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The scandinavian simvastatin survival study (4S)
2. New insights into the pharmacodynamic and pharmacokinetic properties of statins
3. The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vivo: A clue to the mechanism of action of nitrogen-containing bisphosphonates
4. Stimulation of bone formation in vitro and in rodents by statins
5. Statin use, bone mass and fracture: An analysis of two prospective studies
6. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women
7. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients
8. HMG-CoA reductase inhibitors and the risk of fractures
9. Does statin use reduce the risk of fracture in postmenopausal women? Results from the women's health initiative observational study (WHI-OS)
10. Pharmacoepidemiology using a UK database of primary care records
11. The vamp research multipurpose database in the UK
12. Research implications of computerised primary care
13. The UK general practice research database
14. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom
15. Further validation of information recorded on a general practitioner based computerised data resource in the United Kingdom
16. Accuracy of diagnosis of psychosis on general practice computer system
17. The quality of information recorded on a UK database of primary care records: A study of hospitalization due to hypoglycemia and other conditions
18. The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: Validation of study population and results
19. Osteoporosis associated with illness and medications
20. Falls as risk factors for fractures
21. Risk factors for hip fractures in white women
22. Statins and the risk of dementia
23. Use of oral corticosteroids and risk of fractures